Exane Derivatives’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,180
| Closed | -$175K | – | 934 |
|
|
2021
Q3 | $175K | Sell |
4,180
-326
| -7% | -$13.7K | 0.04% | 416 |
|
|
2021
Q2 | $165K | Buy |
4,506
+348
| +8% | +$12.7K | 0.04% | 439 |
|
|
2021
Q1 | $142K | Buy |
4,158
+200
| +5% | +$6.82K | 0.04% | 338 |
|
|
2020
Q4 | $180K | Buy |
3,958
+813
| +26% | +$36.9K | 0.05% | 317 |
|
|
2020
Q3 | $86.5K | Buy |
3,145
+431
| +16% | +$11.9K | 0.03% | 306 |
|
|
2020
Q2 | $100K | Buy |
2,714
+2,700
| +19,286% | +$99.4K | 0.03% | 279 |
|
|
2020
Q1 | $453 | Hold |
14
| – | – | ﹤0.01% | 587 |
|
|
2019
Q4 | $666 | Hold |
14
| – | – | ﹤0.01% | 559 |
|
|
2019
Q3 | $498 | Hold |
14
| – | – | ﹤0.01% | 556 |
|
|
2019
Q2 | $719 | Hold |
14
| – | – | ﹤0.01% | 549 |
|
|
2019
Q1 | $802 | Sell |
14
-252
| -95% | -$14.4K | ﹤0.01% | 487 |
|
|
2018
Q4 | $11.2K | Hold |
266
| – | – | ﹤0.01% | 426 |
|
|
2018
Q3 | $20.7K | Sell |
266
-3,734
| -93% | -$290K | ﹤0.01% | 384 |
|
|
2018
Q2 | $284K | Hold |
4,000
| – | – | 0.05% | 204 |
|
|
2018
Q1 | $114K | Buy |
+4,000
| New | +$114K | 0.02% | 270 |
|